Insulin is produced by specialized beta cells in the pancreas.

Beta cells sense changes associated with incoming nutrients, especially rising blood glucose. Their release of insulin helps the body respond after a meal. This is regulated secretion, not a fixed amount being poured into the circulation regardless of nutritional conditions.

Insulin helps muscle and fat cells take up glucose and encourages nutrient storage. It also acts on the liver to reduce glucose production and support storage as glycogen. Its effects therefore extend beyond a simple picture of opening one door for sugar.

Other pancreatic islet cells produce different hormones. Alpha cells release glucagon, which helps raise available blood glucose when needed, partly through effects on the liver. Blood-glucose control depends on coordinated signals and tissue responses, not on beta cells acting in isolation.

Pancreatic islets are small clusters distributed through the pancreas. They contain several cell types and are richly supplied with blood vessels, allowing hormones to enter the circulation. Most surrounding pancreatic tissue instead contributes to exocrine secretion: digestive juice that reaches the intestine through ducts.

The distinction matters because a hormone is an instruction, whereas a digestive enzyme carries out a chemical reaction on food. Insulin does not chop starch into glucose inside the intestine. Amylase and other digestive enzymes help accomplish breakdown; insulin helps regulate the body’s handling of nutrients once they become available.

Type 1 diabetes develops when an autoimmune process destroys insulin-producing beta cells, resulting in severe insulin deficiency. In type 2 diabetes, cells respond less effectively to insulin and beta-cell secretion eventually fails to meet the body’s needs. The two conditions can therefore involve the same hormone through different underlying mechanisms.

A useful qualification is that not every tissue depends on insulin in the same way to take up glucose. Some cells have glucose transport routes that are not controlled like those in muscle and fat. Saying that insulin is required for every molecule of glucose to enter every cell overstates its role.

Insulin treatment also illustrates the importance of route. Ordinary insulin cannot simply be swallowed as if it were an inert mineral supplement, because it is a protein exposed to digestive breakdown and absorption barriers. Medical insulin formulations and delivery systems are designed around these constraints. Treatment choices depend on the individual condition rather than on the general anatomy alone.

Glucose measurements describe the outcome of this whole system, not beta-cell behavior alone. A high reading can reflect several interacting influences, including liver output and tissue responsiveness. Interpreting the result therefore requires context rather than treating it as a direct count of working pancreatic cells.

A hormone's route is part of its identity as a signal. Beta cells release insulin into circulation, allowing it to influence tissues away from the pancreas. That is fundamentally different from delivering a digestive enzyme into the intestine. The pancreas participates both in processing food outside the internal circulation and in coordinating the use of nutrients after they enter the body.